Intratio
Ricerca quantitativa
Vai al contenuto principale
Riepilogo di mercato IA
Caricamento informazioni di mercato...
  • Accedi
    Il mio account
    Esci

Recursion Pharmaceuticals, Inc. RXRX Previsione azionaria

Predizione di prezzo e analisi basata sull'AI per Recursion Pharmaceuticals, Inc. ยท Aggiornato Giu 04, 2026

Previsione AI a 90 giorni
MANTENERE
7 giorni
โ–ˆโ–ˆ%
30 giorni
โ–ˆโ–ˆ%
90 giorni
โ–ˆโ–ˆ%
Confidenza IA: 39% Correlazione di Spearman
Giugno 04, 2026

Scopri il target di prezzo esatto di RXRX

Crea un account gratuito per sbloccare le predizioni AI per oltre 4.000 titoli

Registrati gratis con Google
โœ“ Account gratuito ยท โœ“ Prova di 30 giorni ยท โœ“ Cancella quando vuoi

Prezzo e mercato

Caricamento grafico...

Statistiche chiave

Capitalizzazione di mercato
$1.84B
Rapporto P/B
1,80x
EPS
$-0,76
ROE
-12,0%
Margine netto
-1199,0%
Fatturato
$66M
Rapporto corrente
5,47x
Rapporto D/E
0,31x

Chi siamo Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. (RXRX) opera nel settore Life Sciences, specificamente nell'industria Biological Products, (No Diagnostic Substances). .

Ramon Martin Chavez (born c. 1964) is an American investment banker and entrepreneur. He is vice chairman and partner of Sixth Street Partners. Previously, he served in a variety of senior roles at Goldman Sachs, including chief information officer (2014โ€“2017), chief financial officer, and global co-head of the firm's Securities Division. Marty was also a partner and member of Goldman's management committee. He was the chief technology officer and co-founder of Quorum Software Systems and CEO and co-founder of Kiodex. โ€ฆ

Life Sciences Biological Products, (No Diagnostic Substances) Nasdaq Small Cap

Biological Products, (No Diagnostic Substances) Aziende comparabili

Azienda Ticker Segnale AI Capitalizzazione di mercato P/E
Acumen Pharmaceuticals, Inc. ABOS โ–ˆโ–ˆ% $165M -x
Abpro Holdings, Inc. ABP โ–ˆโ–ˆ% $310K -x
Abpro Holdings, Inc. ABPO โ–ˆโ–ˆ% $1M -x
Arcellx, Inc. ACLX โ–ˆโ–ˆ% $6.73B -x
Alpha Cognition Inc. ACOG โ–ˆโ–ˆ% $133M -x
Adaptimmune Therapeutics Plc ADAP โ–ˆโ–ˆ% $77M -13,2x
Adma Biologics, Inc. ADMA โ–ˆโ–ˆ% $1.80B 10,9x
Adaptive Biotechnologies Corp ADPT โ–ˆโ–ˆ% $2.78B -x
Adverum Biotechnologies, Inc. ADVM โ–ˆโ–ˆ% $95M -1,8x
Agenus Inc AGEN โ–ˆโ–ˆ% $133M 2,1x
Agentix Corp. AGTX โ–ˆโ–ˆ% $840K -x
Aim Immunotech Inc. AIM โ–ˆโ–ˆ% $11M -x
Aim Immunotech Inc. AIMI โ–ˆโ–ˆ% $1M -x
Alector, Inc. ALEC โ–ˆโ–ˆ% $197M -x
Aligos Therapeutics, Inc. ALGS โ–ˆโ–ˆ% $32M -x
Allogene Therapeutics, Inc. ALLO โ–ˆโ–ˆ% $690M -x
Alvotech ALVO โ–ˆโ–ˆ% $980M -x
Amgen Inc AMGN โ–ˆโ–ˆ% $182.54B 23,4x
Apogee Therapeutics, Inc. APGE โ–ˆโ–ˆ% $6.30B -x
Aptose Biosciences Inc. APTOF โ–ˆโ–ˆ% $4M -x
Argenx Se ARGX โ–ˆโ–ˆ% $50.32B -x
Armata Pharmaceuticals, Inc. ARMP โ–ˆโ–ˆ% $277M -x
Artiva Biotherapeutics, Inc. ARTV โ–ˆโ–ˆ% $354M -x
Leonabio, Inc. ATHA โ–ˆโ–ˆ% $23M -0,2x
Atara Biotherapeutics, Inc. ATRA โ–ˆโ–ˆ% $82M -x
Atyr Pharma Inc ATYR โ–ˆโ–ˆ% $49M -x
Aura Biosciences, Inc. AURA โ–ˆโ–ˆ% $711M -x
Autolus Therapeutics Plc AUTL โ–ˆโ–ˆ% $431M -x
Anavex Life Sciences โ€ฆ AVXL โ–ˆโ–ˆ% $262M -x
Bioatla, Inc. BCAB โ–ˆโ–ˆ% $6M -x
Biocardia, Inc. BCDA โ–ˆโ–ˆ% $10M -x
Brainstorm Cell Therapeutics โ€ฆ BCLI โ–ˆโ–ˆ% $8M -x
Biocryst Pharmaceuticals Inc BCRX โ–ˆโ–ˆ% $2.10B -x
Black Diamond Therapeutics, โ€ฆ BDTX โ–ˆโ–ˆ% $124M -x
Beam Therapeutics Inc. BEAM โ–ˆโ–ˆ% $3.04B -x
Biogen Inc. BIIB โ–ˆโ–ˆ% $28.85B 21,0x
Biontech Se BNTX โ–ˆโ–ˆ% $22.75B -x
Cabaletta Bio, Inc. CABA โ–ˆโ–ˆ% $554M -x
Candel Therapeutics, Inc. CADL โ–ˆโ–ˆ% $685M -x
C4 Therapeutics, Inc. CCCC โ–ˆโ–ˆ% $412M -x
Cidara Therapeutics, Inc. CDTX โ–ˆโ–ˆ% $6.49B -1,0x
Creative Medical Technology โ€ฆ CELZ โ–ˆโ–ˆ% $8M -x
Cero Therapeutics Holdings, โ€ฆ CERO โ–ˆโ–ˆ% $540K -x
Cullinan Therapeutics, Inc. CGEM โ–ˆโ–ˆ% $935M -x
Compugen Ltd CGEN โ–ˆโ–ˆ% $210M 3,0x
Cg Oncology, Inc. CGON โ–ˆโ–ˆ% $4.79B -x
Cognition Therapeutics Inc CGTX โ–ˆโ–ˆ% $127M -x
Coherus Oncology, Inc. CHRS โ–ˆโ–ˆ% $238M 1,3x
Calidi Biotherapeutics, Inc. CLDI โ–ˆโ–ˆ% $3M -x
Cellectis S.A. CLLS โ–ˆโ–ˆ% $311M -x
Compass Therapeutics, Inc. CMPX โ–ˆโ–ˆ% $380M -x
Mosaic Immunoengineering Inc. CPMV โ–ˆโ–ˆ% $2M -x
Caribou Biosciences, Inc. CRBU โ–ˆโ–ˆ% $142M -1,5x
Cardiff Oncology, Inc. CRDF โ–ˆโ–ˆ% $96M -x
Cardiol Therapeutics Inc. CRDL โ–ˆโ–ˆ% $129M -x
Curis Inc CRIS โ–ˆโ–ˆ% $20M -x
Crispr Therapeutics Ag CRSP โ–ˆโ–ˆ% $5.02B -x
Champions Oncology, Inc. CSBR โ–ˆโ–ˆ% $79M -x
Cel Sci Corp CVM โ–ˆโ–ˆ% $21M -x
Dbv Technologies S.A. DBVT โ–ˆโ–ˆ% $1.05B -x
Dbv Technologies S.A. DBVTF โ–ˆโ–ˆ% $10K -x
Ginkgo Bioworks Holdings, โ€ฆ DNA โ–ˆโ–ˆ% $538M -x
Denali Therapeutics Inc. DNLI โ–ˆโ–ˆ% $3.12B -x
Precision Biosciences Inc DTIL โ–ˆโ–ˆ% $156M -x
Dyadic International Inc DYAI โ–ˆโ–ˆ% $26M -x
Editas Medicine, Inc. EDIT โ–ˆโ–ˆ% $427M -x
Eloxx Pharmaceuticals, Inc. ELOX โ–ˆโ–ˆ% $7M -x
Elutia Inc. ELUT โ–ˆโ–ˆ% $46M 0,9x
Engene Therapeutics Inc. ENGN โ–ˆโ–ˆ% $112M -x
Entera Bio Ltd. ENTX โ–ˆโ–ˆ% $57M -x
Viskase Holdings, Inc. ENZN โ–ˆโ–ˆ% $39M -x
Estrella Immunopharma, Inc. ESLA โ–ˆโ–ˆ% $49M -x
Evaxion A/S EVAX โ–ˆโ–ˆ% $30M -x
Exelixis, Inc. EXEL โ–ˆโ–ˆ% $13.09B 15,7x
Exozymes Inc. EXOZ โ–ˆโ–ˆ% $80M -x
Fate Therapeutics Inc FATE โ–ˆโ–ˆ% $258M -x
4d Molecular Therapeutics, โ€ฆ FDMT โ–ˆโ–ˆ% $514M -x
Fennec Pharmaceuticals Inc. FENC โ–ˆโ–ˆ% $316M -x
Finch Therapeutics Group, โ€ฆ FNCH โ–ˆโ–ˆ% $12M 0,5x
Finch Therapeutics Group, โ€ฆ FNCHQ โ–ˆโ–ˆ% $12M 0,5x
Futuretech Ii Acquisition โ€ฆ FTII โ–ˆโ–ˆ% $52M -x
Futuretech Ii Acquisition โ€ฆ FTIIU โ–ˆโ–ˆ% $14M -x
Gilead Sciences, Inc. GILD โ–ˆโ–ˆ% $160.21B 17,4x
Monte Rosa Therapeutics, โ€ฆ GLUE โ–ˆโ–ˆ% $1.48B -x
Genenta Science S.P.A. GNTA โ–ˆโ–ˆ% $50M -x
Green Planet Bio โ€ฆ GPLB โ–ˆโ–ˆ% $260K -x
Greenland Mines Ltd GRML โ–ˆโ–ˆ% $40M -x
Halozyme Therapeutics, Inc. HALO โ–ˆโ–ˆ% $8.28B 23,7x
Humacyte, Inc. HUMA โ–ˆโ–ˆ% $311M -x
Immunitybio, Inc. IBRX โ–ˆโ–ˆ% $7.52B -x
Inhibikase Therapeutics, Inc. IKT โ–ˆโ–ˆ% $220M -x
Imagenebio, Inc. IMA โ–ˆโ–ˆ% $61M -x
Immunocore Holdings Plc IMCR โ–ˆโ–ˆ% $1.46B -x
Immatics N.V. IMTX โ–ˆโ–ˆ% $1.37B -x
Immunovant, Inc. IMVT โ–ˆโ–ˆ% $6.35B -x
In8bio, Inc. INAB โ–ˆโ–ˆ% $15M -x
Inhibrx Biosciences, Inc. INBX โ–ˆโ–ˆ% $873M -6,8x
Mink Therapeutics, Inc. INKT โ–ˆโ–ˆ% $61M -x
Inmune Bio, Inc. INMB โ–ˆโ–ˆ% $35M -x
Intensity Therapeutics, Inc. INTS โ–ˆโ–ˆ% $10M -x
Iovance Biotherapeutics, Inc. IOVA โ–ˆโ–ˆ% $1.66B -x
Century Therapeutics, Inc. IPSC โ–ˆโ–ˆ% $373M -x
Invivyd, Inc. IVVD โ–ˆโ–ˆ% $311M -x
Jasper Therapeutics, Inc. JSPR โ–ˆโ–ˆ% $15M -x
Kalaris Therapeutics, Inc. KLRS โ–ˆโ–ˆ% $109M -x
Klotho Neurosciences, Inc. KLTO โ–ˆโ–ˆ% $56M -x
Kodiak Sciences Inc. KOD โ–ˆโ–ˆ% $2.11B -x
Krystal Biotech, Inc. KRYS โ–ˆโ–ˆ% $8.88B 39,5x
Kymera Therapeutics, Inc. KYMR โ–ˆโ–ˆ% $6.02B -x
Kyverna Therapeutics, Inc. KYTX โ–ˆโ–ˆ% $473M -x
Ladrx Corp LADX โ–ˆโ–ˆ% $20K -x
Lineage Cell Therapeutics, โ€ฆ LCTX โ–ˆโ–ˆ% $299M -x
Lenz Therapeutics, Inc. LENZ โ–ˆโ–ˆ% $220M -x
Atyr Pharma Inc LIFE โ–ˆโ–ˆ% $1.66B -x
Liminatus Pharma, Inc. LIMN โ–ˆโ–ˆ% $7M -x
Leonabio, Inc. LONA โ–ˆโ–ˆ% $81M -x
Lexeo Therapeutics, Inc. LXEO โ–ˆโ–ˆ% $333M -x
Maze Therapeutics, Inc. MAZE โ–ˆโ–ˆ% $1.38B -x
Mesoblast Ltd MESO โ–ˆโ–ˆ% $1.88B -x
Meiragtx Holdings Plc MGTX โ–ˆโ–ˆ% $870M -x
Metagenomi Therapeutics, Inc. MGX โ–ˆโ–ˆ% $50M -x
Molecular Partners Ag MOLN โ–ˆโ–ˆ% $163M -x
Moderna, Inc. MRNA โ–ˆโ–ˆ% $19.48B -x
Neurocrine Biosciences Inc NBIX โ–ˆโ–ˆ% $16.61B 24,8x
Nkgen Biotech, Inc. NKGN โ–ˆโ–ˆ% $2M -0,1x
Neumora Therapeutics, Inc. NMRA โ–ˆโ–ˆ% $313M -x
Novavax Inc NVAX โ–ˆโ–ˆ% $1.68B -x
Ocugen, Inc. OCGN โ–ˆโ–ˆ% $440M -x
Outlook Therapeutics, Inc. OTLK โ–ˆโ–ˆ% $98M -x
Palisade Bio, Inc. PALI โ–ˆโ–ˆ% $323M -x
Passage Bio, Inc. PASG โ–ˆโ–ˆ% $19M -x
Vaxcyte, Inc. PCVX โ–ˆโ–ˆ% $6.77B -x
Biomx Inc. PHGE โ–ˆโ–ˆ% $9M -x
Pluri Inc. PLUR โ–ˆโ–ˆ% $25M -x
Protalix Biotherapeutics, Inc. PLX โ–ˆโ–ˆ% $156M 10,2x
Pharmacyte Biotech, Inc. PMCB โ–ˆโ–ˆ% $8M -x
Prime Medicine, Inc. PRME โ–ˆโ–ˆ% $567M -x
Prokidney Corp. PROK โ–ˆโ–ˆ% $523M -x
Pelthos Therapeutics Inc. PTHS โ–ˆโ–ˆ% $87M -x
Qiagen N.V. QGEN โ–ˆโ–ˆ% $7.91B -x
Quince Therapeutics, Inc. QNCX โ–ˆโ–ˆ% $20M 2,4x
Qrons Inc. QRON โ–ˆโ–ˆ% $150K -x
Replimune Group, Inc. REPL โ–ˆโ–ˆ% $795M -x
Repligen Corp RGEN โ–ˆโ–ˆ% $6.87B 133,6x
Regenxbio Inc. RGNX โ–ˆโ–ˆ% $345M -x
Relay Therapeutics, Inc. RLAY โ–ˆโ–ˆ% $3.33B -x
Revolution Medicines, Inc. RVMD โ–ˆโ–ˆ% $31.23B -x
Recursion Pharmaceuticals, Inc. RXRX โ–ˆโ–ˆ% $1.84B -x
Sab Biotherapeutics, Inc. SABS โ–ˆโ–ˆ% $257M -x
Sana Biotechnology, Inc. SANA โ–ˆโ–ˆ% $842M -x
Scilex Holding Co SCLX โ–ˆโ–ˆ% $50M -x
Scinai Immunotherapeutics Ltd. SCNI โ–ˆโ–ˆ% $2M -x
Sangamo Therapeutics, Inc SGMO โ–ˆโ–ˆ% $86M -x
Solid Biosciences Inc. SLDB โ–ˆโ–ˆ% $674M -x
Silexion Therapeutics Corp SLXN โ–ˆโ–ˆ% $2M -x
Senti Biosciences Holdings, โ€ฆ SNTI โ–ˆโ–ˆ% $30M -x
Scholar Rock Holding โ€ฆ SRRK โ–ˆโ–ˆ% $5.32B -x
Surrozen, Inc./De SRZN โ–ˆโ–ˆ% $282M -x
Sutro Biopharma, Inc. STRO โ–ˆโ–ˆ% $450M -x
Protara Therapeutics, Inc. TARA โ–ˆโ–ˆ% $240M -x
Tarsus Pharmaceuticals, Inc. TARS โ–ˆโ–ˆ% $2.60B -x
Tc Biopharm (Holdings) โ€ฆ TCBPY โ–ˆโ–ˆ% $10K -x
Tscan Therapeutics, Inc. TCRX โ–ˆโ–ˆ% $66M -x
Bio-Techne Corp TECH โ–ˆโ–ˆ% $8.21B 74,9x
Tectonic Therapeutic, Inc. TECX โ–ˆโ–ˆ% $535M -x
Instil Bio, Inc. TIL โ–ˆโ–ˆ% $56M -x
Tenaya Therapeutics, Inc. TNYA โ–ˆโ–ˆ% $178M -x
Tourmaline Bio, Inc. TRML โ–ˆโ–ˆ% $1.23B -3,5x
Taysha Gene Therapies, โ€ฆ TSHA โ–ˆโ–ˆ% $1.63B -x
Titan Pharmaceuticals Inc TTNP โ–ˆโ–ˆ% $6M -0,5x
Tevogen Bio Holdings โ€ฆ TVGN โ–ˆโ–ˆ% $42M -x
Twist Bioscience Corp TWST โ–ˆโ–ˆ% $4.83B -x
Voyager Acquisition Corp./Cayman โ€ฆ VACH โ–ˆโ–ˆ% $335M 49,8x
Voyager Acquisition Corp./Cayman โ€ฆ VACHU โ–ˆโ–ˆ% $68M 6,7x
Valneva Se VALN โ–ˆโ–ˆ% $540M -x
Vericel Corp VCEL โ–ˆโ–ˆ% $1.86B 86,9x
Vir Biotechnology, Inc. VIR โ–ˆโ–ˆ% $1.48B -x
Vivosim Labs, Inc. VIVS โ–ˆโ–ˆ% $3M -x
Vor Biopharma Inc. VOR โ–ˆโ–ˆ% $797M -x
Vaxart, Inc. VXRT โ–ˆโ–ˆ% $145M 3,9x
Voyager Therapeutics, Inc. VYGR โ–ˆโ–ˆ% $226M -x
Windtree Therapeutics Inc โ€ฆ WINT โ–ˆโ–ˆ% $510K -x
X4 Pharmaceuticals, Inc XFOR โ–ˆโ–ˆ% $387M -x
Zeo Scientifix, Inc. ZEOX โ–ˆโ–ˆ% $14M -x
Zivo Bioscience, Inc. ZIVO โ–ˆโ–ˆ% $14M -x
Zura Bio Ltd ZURA โ–ˆโ–ˆ% $366M -x

FAQ

  • Recursion Pharmaceuticals, Inc. รจ un buon titolo da acquistare?

    La nostra AI analizza Recursion Pharmaceuticals, Inc. quotidianamente. Controlla il segnale sopra per l'ultima raccomandazione. Fai sempre le tue ricerche prima di investire.

  • Quanto sono accurate le previsioni di Recursion Pharmaceuticals, Inc.?

    La nostra AI raggiunge una correlazione di Spearman del 39% per questo titolo, con una precisione media superiore al 67% su oltre 4.000 titoli analizzati quotidianamente.

  • Con quale frequenza vengono aggiornate le previsioni?

    Le previsioni di Recursion Pharmaceuticals, Inc. vengono aggiornate quotidianamente utilizzando i dati di mercato piรน recenti e i modelli AI.

Pronto a investire in modo piรน intelligente?

Unisciti a migliaia di investitori che utilizzano previsioni azionarie basate sull'AI

Registrati gratis
โœ“ Account gratuito ยท โœ“ Oltre 4.000 titoli ยท โœ“ Aggiornamenti giornalieri

Cerchi un'analisi piรน approfondita di Recursion Pharmaceuticals, Inc.?

Visualizza l'analisi completa di livello istituzionale su Intratio โ†’

Le predizioni AI si basano su modelli storici e non dovrebbero essere l'unica base per le decisioni di investimento. Le performance passate non garantiscono risultati futuri. Fai sempre le tue ricerche.

I miei portafogli

Dashboard investimenti

Caricamento del tuo portafoglio...